← Eichor
Condition: Anthracycline Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anthracycline

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
NA · 24 location(s) · Fundación Centro Nacional de Investigaciones Cardiovasculare · NCT05223413Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and
Phase N/A · 1 location(s) · Centre Paul Strauss · NCT06443645Cardiac Dysfunction in Childhood Cancer Survivors
Phase N/A · 6 location(s) · University of Bern · NCT03790943Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
Phase 2 · 28 location(s) · GWT-TUD GmbH · NCT04061239De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT06692725Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
Phase 3 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06744504Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer
Phase 3 · 18 location(s) · Latin American Cooperative Oncology Group · NCT04540692Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy
Phase 3 · 1 location(s) · University of Campinas, Brazil · NCT06711185Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients
Phase N/A · 1 location(s) · IRCCS Burlo Garofolo · NCT06898320Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatme
Phase N/A · 79 location(s) · Children's Oncology Group · NCT01790152Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
NA · 8 location(s) · University Hospital, Tours · NCT04937309Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lym
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774326Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Phase 1/Phase 2 · 1 location(s) · Texas Tech University Health Sciences Center · NCT03934905Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Phase 2 · 1 location(s) · University Hospital, Akershus · NCT05732051NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT06845319ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07191730Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT02962661Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Inel
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06045247CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Phase 3 · 3 location(s) · 4th Military Clinical Hospital with Polyclinic, Poland · NCT06304857Cardiotoxicity in Breast Cancer Patients
Phase 4 · 1 location(s) · Helwan University · NCT06491680Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
NA · 3 location(s) · Virginia Commonwealth University · NCT07426913Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
Phase 2 · 1 location(s) · Iacopo Sardi · NCT06297512Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthra
Phase 1 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06766266Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
NA · 1 location(s) · Erasmus Medical Center · NCT06622954Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML
Phase 2 · 2 location(s) · The First Affiliated Hospital of Soochow University · NCT06429098Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic B
Phase 2 · 8 location(s) · SCRI Development Innovations, LLC · NCT05748834A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 · 67 location(s) · Eli Lilly and Company · NCT07169851A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
Phase 1 · 1 location(s) · Xijing Hospital · NCT07178171Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiot
NA · 1 location(s) · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RB · NCT07528586At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure
NA · 1 location(s) · Children's Hospital Los Angeles · NCT06826534
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.